Name | Number of supported studies | Average coverage | |
---|---|---|---|
OFF-bipolar cell | 3 studies | 34% ± 8% | |
rod bipolar cell | 3 studies | 20% ± 4% |
Insufficient scRNA-seq data for expression of GABRR3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 14% | 0.83 | 32 / 226 | 9% | 0.23 | 37 / 406 |
spleen | 22% | 0.72 | 54 / 241 | 0% | 0 | 0 / 0 |
bladder | 14% | 0.38 | 3 / 21 | 3% | 0.05 | 13 / 504 |
thymus | 13% | 0.38 | 88 / 653 | 0% | 0 | 0 / 605 |
brain | 8% | 0.24 | 213 / 2642 | 1% | 0.01 | 4 / 705 |
adrenal gland | 6% | 0.15 | 15 / 258 | 0% | 0 | 0 / 230 |
muscle | 5% | 0.12 | 39 / 803 | 0% | 0 | 0 / 0 |
lung | 4% | 0.10 | 24 / 578 | 1% | 0.01 | 7 / 1155 |
pancreas | 1% | 0.02 | 4 / 328 | 3% | 0.10 | 5 / 178 |
eye | 0% | 0 | 0 / 0 | 4% | 0.25 | 3 / 80 |
intestine | 4% | 0.10 | 36 / 966 | 0% | 0 | 0 / 527 |
kidney | 3% | 0.08 | 3 / 89 | 0% | 0.00 | 1 / 901 |
peripheral blood | 3% | 0.10 | 31 / 929 | 0% | 0 | 0 / 0 |
prostate | 3% | 0.07 | 7 / 245 | 0% | 0 | 0 / 502 |
breast | 2% | 0.07 | 11 / 459 | 0% | 0.01 | 5 / 1118 |
blood vessel | 3% | 0.08 | 37 / 1335 | 0% | 0 | 0 / 0 |
uterus | 2% | 0.05 | 4 / 170 | 0% | 0.00 | 1 / 459 |
adipose | 2% | 0.06 | 30 / 1204 | 0% | 0 | 0 / 0 |
skin | 2% | 0.06 | 40 / 1809 | 0% | 0 | 0 / 472 |
esophagus | 2% | 0.04 | 26 / 1445 | 0% | 0 | 0 / 183 |
heart | 2% | 0.05 | 15 / 861 | 0% | 0 | 0 / 0 |
stomach | 1% | 0.03 | 5 / 359 | 0% | 0 | 0 / 286 |
ovary | 1% | 0.02 | 2 / 180 | 0% | 0 | 0 / 430 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007214 | Biological process | gamma-aminobutyric acid signaling pathway |
GO_1902476 | Biological process | chloride transmembrane transport |
GO_0042391 | Biological process | regulation of membrane potential |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_1902711 | Cellular component | GABA-A receptor complex |
GO_0005575 | Cellular component | cellular_component |
GO_1902495 | Cellular component | transmembrane transporter complex |
GO_0034707 | Cellular component | chloride channel complex |
GO_0045202 | Cellular component | synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0043005 | Cellular component | neuron projection |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0004890 | Molecular function | GABA-A receptor activity |
GO_0030594 | Molecular function | neurotransmitter receptor activity |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0005254 | Molecular function | chloride channel activity |
GO_0022851 | Molecular function | GABA-gated chloride ion channel activity |
Gene name | GABRR3 |
Protein name | Gamma-aminobutyric acid receptor subunit rho-3 (GABA(A) receptor subunit rho-3) (GABA(C) receptor) |
Synonyms | |
Description | FUNCTION: GABA, the major inhibitory neurotransmitter in the vertebrate brain, mediates neuronal inhibition by binding to the GABA/benzodiazepine receptor and opening an integral chloride channel. . |
Accessions | ENST00000472788.6 A8MPY1 |